Formulation to Clinic―Navigating the Complexities of Ophthalmic Drug Development
Helping You Navigate the Complexities of Ophthalmic Drug Development
Ophthalmic drug development comes with a unique set of challenges and complexities. To maximize your chance of success, it is best to rely on a drug development partner with regulatory knowledge, scientific and technical expertise, and a thorough understanding of the market in this growing therapeutic area.
Altasciences’ clients benefit from working with a single CRO/CDMO partner, from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in both time and cost savings.
Learn about the key considerations and critical steps in each phase of ophthalmic drug development, including case studies, in this issue of The Altascientist.
![The Altascientist issue 27 - Ophthalmic](/sites/default/files/inline-images/Altascientist_issue27_Ophthalmic_thumbnail2.png)
Have questions? Speak with one of our experts.
You might also be interested in:
- Webpage: Full-Service Drug Development Solutions
- Scientific Article: Terminal Sterilization of Pharmaceutical Products
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.